Exact Mass: 319.11437020000005

Exact Mass Matches: 319.11437020000005

Found 93 metabolites which its exact mass value is equals to given mass value 319.11437020000005, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tryptophyl-Aspartate

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}butanedioate

C15H17N3O5 (319.1168152)


Tryptophyl-Aspartate is a dipeptide composed of tryptophan and aspartate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Aspartyl-Tryptophan

3-Amino-3-{[1-carboxy-2-(1H-indol-3-yl)ethyl]-C-hydroxycarbonimidoyl}propanoate

C15H17N3O5 (319.1168152)


Aspartyl-Tryptophan is a dipeptide composed of aspartate and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Salbutamol 4-O-sulfate

{4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenyl}oxidanesulfonic acid

C13H21NO6S (319.10895260000007)


Salbutamol 4-O-sulfate is a metabolite of salbutamol. Salbutamol or albuterol is a short-acting β2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease. It is marketed as Ventolin among other brand names. Salbutamol was the first selective β2-receptor agonist to be marketed — in 1968. It was first sold by Allen & Hanburys under the brand name Ventolin. The drug was an instant success, and has been used for the treatment of asthma ever since. (Wikipedia)

   

1-(2-Methylbenzo[d]oxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea

1-(2-Methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea hydrochloride

C17H13N5O2 (319.1069198)


   

N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline

3-[(3,5-Dimethoxyphenyl)(ethyl)amino]-2-hydroxypropane-1-sulphonic acid

C13H21NO6S (319.10895260000007)


   

4-Hydroxy-5-[3-[(1-methylcyclohexyl)methoxy]phenyl]-3H-1,3-thiazol-2-one

4-hydroxy-5-{3-[(1-methylcyclohexyl)methoxy]phenyl}-2,3-dihydro-1,3-thiazol-2-one

C17H21NO3S (319.12420760000003)


   

4,5,6,7,8-pentamethoxyfuroquinoline

4,5,6,7,8-pentamethoxyfuroquinoline

C16H17NO6 (319.1055822)


   
   
   

6-methoxy-N-[2-(trifluoromethyl)phenyl]-3,4-dihydro-2H-naphthalen-1-imine

6-methoxy-N-[2-(trifluoromethyl)phenyl]-3,4-dihydro-2H-naphthalen-1-imine

C18H16F3NO (319.1183922)


   

4,5-Dehydroguadiscine

4,5-Dehydroguadiscine

C20H17NO3 (319.1208372)


   

physarorubinic acid B

physarorubinic acid B

C16H17NO6 (319.1055822)


   

1-N-beta-D-ribofuranosylmakaluvamine I|N-1-beta-D-ribofuranosylmakalucamine I|N-1-beta-D-ribofuranosylmakaluvamine I

1-N-beta-D-ribofuranosylmakaluvamine I|N-1-beta-D-ribofuranosylmakalucamine I|N-1-beta-D-ribofuranosylmakaluvamine I

C15H17N3O5 (319.1168152)


   

(S)-2-(3,4-dihydroxybenzoylamino)-3-(3,4-dihydroxyphenyl)propanol|nigerrimin B

(S)-2-(3,4-dihydroxybenzoylamino)-3-(3,4-dihydroxyphenyl)propanol|nigerrimin B

C16H17NO6 (319.1055822)


   
   

(1R*,3S*)-1-(5-hydroxymethylfuran-2-yl)-3-carboxy-6-hydroxy-8-methoxy-1,2,3,4-tetrahydroisoquinoline

(1R*,3S*)-1-(5-hydroxymethylfuran-2-yl)-3-carboxy-6-hydroxy-8-methoxy-1,2,3,4-tetrahydroisoquinoline

C16H17NO6 (319.1055822)


   
   
   
   
   
   
   
   
   
   
   

Asp-TRP

2-[2-amino-3-(1H-indol-3-yl)propanamido]butanedioic acid

C15H17N3O5 (319.1168152)


A dipeptide formed from L-alpha-aspartyl and L-tryptophan residues.

   

TRP-Asp

3-amino-3-{[1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C15H17N3O5 (319.1168152)


A dipeptide formed from L-tryptophan and L-aspartic acid residues.

   
   

ETHYL5-CHLOROTHIOPHENE-2-CARBOXLATE

ETHYL5-CHLOROTHIOPHENE-2-CARBOXLATE

C17H21NO3S (319.12420760000003)


   

(S)-(+)-N-(1-(1-NAPHTHYL)ETHYL)PHTHALAM&

(S)-(+)-N-(1-(1-NAPHTHYL)ETHYL)PHTHALAM&

C20H17NO3 (319.1208372)


   

2-[4-[2-nitro-4-(trifluoromethyl)phenyl]piperazino]-1-ethanol

2-[4-[2-nitro-4-(trifluoromethyl)phenyl]piperazino]-1-ethanol

C13H16F3N3O3 (319.11437020000005)


   

(2R)-2-[(4-Ethyl-2,3-dioxopiperazinyl)carbonylamino]-2-phenylacetic acid

(2R)-2-[(4-Ethyl-2,3-dioxopiperazinyl)carbonylamino]-2-phenylacetic acid

C15H17N3O5 (319.1168152)


   

4-Aminobenzo-15-crown-5 hydrochloride

4-Aminobenzo-15-crown-5 hydrochloride

C14H22ClNO5 (319.1186432)


   

NAPHTHOL AS-D ACETATE

NAPHTHOL AS-D ACETATE

C20H17NO3 (319.1208372)


   

2-[4-(4-hydroxybut-2-ynyl)piperazin-1-yl]-3-nitrobenzoic acid

2-[4-(4-hydroxybut-2-ynyl)piperazin-1-yl]-3-nitrobenzoic acid

C15H17N3O5 (319.1168152)


   

Methanone, [4-(4-chlorophenyl)-1-piperazinyl](3,5-dimethyl-4-isoxazolyl)

Methanone, [4-(4-chlorophenyl)-1-piperazinyl](3,5-dimethyl-4-isoxazolyl)

C16H18ClN3O2 (319.1087478)


   
   

(E)-P,P-diphenyl-N-(1-phenylethylidene)phosphinic amide

(E)-P,P-diphenyl-N-(1-phenylethylidene)phosphinic amide

C20H18NOP (319.1125948)


   

Methanone, [4-(2-chlorophenyl)-1-piperazinyl](3,5-dimethyl-4-isoxazolyl)-

Methanone, [4-(2-chlorophenyl)-1-piperazinyl](3,5-dimethyl-4-isoxazolyl)-

C16H18ClN3O2 (319.1087478)


   

(1-(tert-Butoxycarbonyl)-7-(methoxycarbonyl)-1H-indol-2-yl)boronic acid

(1-(tert-Butoxycarbonyl)-7-(methoxycarbonyl)-1H-indol-2-yl)boronic acid

C15H18BNO6 (319.12271180000005)


   

[4-methoxycarbonyl-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

[4-methoxycarbonyl-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

C15H18BNO6 (319.12271180000005)


   

(1-(tert-Butoxycarbonyl)-6-(methoxycarbonyl)-1H-indol-2-yl)boronic acid

(1-(tert-Butoxycarbonyl)-6-(methoxycarbonyl)-1H-indol-2-yl)boronic acid

C15H18BNO6 (319.12271180000005)


   

1-Boc-4-(4-Bromobutyl)piperidine

1-Boc-4-(4-Bromobutyl)piperidine

C14H26BrNO2 (319.1146796)


   

(1-(tert-Butoxycarbonyl)-5-(methoxycarbonyl)-1H-indol-2-yl)boronic acid

(1-(tert-Butoxycarbonyl)-5-(methoxycarbonyl)-1H-indol-2-yl)boronic acid

C15H18BNO6 (319.12271180000005)


   

Sumanirole Maleate

Sumanirole Maleate

C15H17N3O5 (319.1168152)


Sumanirole maleate (U-95666E; PNU-95666E) is a highly selective D2 receptor full agonist with an ED50 of about 46 nM. Sumanirole plays an important role in the research of Parkinson's disease and restless leg syndrome[1].

   

(R)-(-)-N-(1-(1-NAPHTHYL)ETHYL)PHTHALAMI C ACID

(R)-(-)-N-(1-(1-NAPHTHYL)ETHYL)PHTHALAMI C ACID

C20H17NO3 (319.1208372)


   

Ethyl 4-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)-3-oxobutanoate

Ethyl 4-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)-3-oxobutanoate

C16H17NO6 (319.1055822)


   

4,4,4-Methanetriyltribenzonitrile

4,4,4-Methanetriyltribenzonitrile

C22H13N3 (319.11094180000003)


   

3-[3-Acetyl-4-hydroxy-2-(4-methoxy-phenyl)-5-oxo-2,5-dihydro-pyrrol-1-yl]-propionic acid

3-[3-Acetyl-4-hydroxy-2-(4-methoxy-phenyl)-5-oxo-2,5-dihydro-pyrrol-1-yl]-propionic acid

C16H17NO6 (319.1055822)


   

Methyl 3-(benzyloxy)-1-(2,2-dihydroxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate

Methyl 3-(benzyloxy)-1-(2,2-dihydroxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate

C16H17NO6 (319.1055822)


   
   
   
   

5-(2-Fluorophenyl)-N-(Pyridin-4-Ylmethyl)pyrazolo[1,5-A]pyrimidin-7-Amine

5-(2-Fluorophenyl)-N-(Pyridin-4-Ylmethyl)pyrazolo[1,5-A]pyrimidin-7-Amine

C18H14FN5 (319.1233176)


   

6-(2-Fluorophenyl)-N-(Pyridin-3-Ylmethyl)imidazo[1,2-A]pyrazin-8-Amine

6-(2-Fluorophenyl)-N-(Pyridin-3-Ylmethyl)imidazo[1,2-A]pyrazin-8-Amine

C18H14FN5 (319.1233176)


   

{2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-(4-hydroxybenzylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid

{2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-(4-hydroxybenzylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid

C15H17N3O5 (319.1168152)


   

(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate

(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate

C17H19O6- (319.1181574)


   

N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline

N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline

C13H21NO6S (319.10895260000007)


   
   

1-[[(1,5-Dimethyl-3-pyrazolyl)-oxomethyl]amino]-3-(2-methoxyphenyl)thiourea

1-[[(1,5-Dimethyl-3-pyrazolyl)-oxomethyl]amino]-3-(2-methoxyphenyl)thiourea

C14H17N5O2S (319.1102902)


   

3,5-dimethyl-1H-pyrrole-2,4-dicarboxylic acid O4-ethyl ester O2-[(2-fluorophenyl)methyl] ester

3,5-dimethyl-1H-pyrrole-2,4-dicarboxylic acid O4-ethyl ester O2-[(2-fluorophenyl)methyl] ester

C17H18FNO4 (319.12198)


   

4-acetyl-3,5-dimethyl-1H-pyrrole-2-carboxylic acid (5-methoxycarbonyl-2-furanyl)methyl ester

4-acetyl-3,5-dimethyl-1H-pyrrole-2-carboxylic acid (5-methoxycarbonyl-2-furanyl)methyl ester

C16H17NO6 (319.1055822)


   

N-(4-fluorophenyl)-1-(3-methylphenyl)-4-pyrazolo[3,4-d]pyrimidinamine

N-(4-fluorophenyl)-1-(3-methylphenyl)-4-pyrazolo[3,4-d]pyrimidinamine

C18H14FN5 (319.1233176)


   

1-(4-Methoxyanilino)-3-(4-methoxyphenyl)sulanylpropan-2-ol

1-(4-Methoxyanilino)-3-(4-methoxyphenyl)sulanylpropan-2-ol

C17H21NO3S (319.12420760000003)


   
   
   
   
   
   
   

N-acetylmethionylglutamine

N-acetylmethionylglutamine

C12H21N3O5S (319.1201856)


   

(N-Trifluoroacetylamino)methylphosphonic acid dibutyl ester

(N-Trifluoroacetylamino)methylphosphonic acid dibutyl ester

C11H21F3NO4P (319.11602320000003)


   

3-Methyl-4-phenacyl-1-para-tolyl-3-pyrroline-2,5-dione

3-Methyl-4-phenacyl-1-para-tolyl-3-pyrroline-2,5-dione

C20H17NO3 (319.1208372)


   

Mycophenolate

Mycophenolate

C17H19O6 (319.1181574)


A monocarboxylic acid anion resulting from the removal of a proton from the carboxy group of mycophenolic acid.

   

SB 334867

1-(2-Methylbenzo[d]oxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea

C17H13N5O2 (319.1069198)


   

4,5,6,7,8-pentamethoxyfuro[2,3-b]quinoline

4,5,6,7,8-pentamethoxyfuro[2,3-b]quinoline

C16H17NO6 (319.1055822)


   

(2z)-n-(4-{[(2e)-3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

(2z)-n-(4-{[(2e)-3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

C17H21NO3S (319.12420760000003)


   

n-[1-(3,4-dihydroxyphenyl)-3-hydroxypropan-2-yl]-3,4-dihydroxybenzenecarboximidic acid

n-[1-(3,4-dihydroxyphenyl)-3-hydroxypropan-2-yl]-3,4-dihydroxybenzenecarboximidic acid

C16H17NO6 (319.1055822)


   

n-(4-{[3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

n-(4-{[3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

C17H21NO3S (319.12420760000003)


   

10-amino-2-[(3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

10-amino-2-[(3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

C15H17N3O5 (319.1168152)


   

methyl 2-(1,2-dimethoxy-2-oxoethyl)-1-methyl-4-oxoquinoline-3-carboxylate

methyl 2-(1,2-dimethoxy-2-oxoethyl)-1-methyl-4-oxoquinoline-3-carboxylate

C16H17NO6 (319.1055822)


   

methyl 4-methyl-6-(1,4,6-trihydroxy-3-oxoisoindol-5-yl)hex-4-enoate

methyl 4-methyl-6-(1,4,6-trihydroxy-3-oxoisoindol-5-yl)hex-4-enoate

C16H17NO6 (319.1055822)


   

(2e)-n-(4-{[(2e)-3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

(2e)-n-(4-{[(2e)-3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

C17H21NO3S (319.12420760000003)


   

methyl 2-[(1s)-1,2-dimethoxy-2-oxoethyl]-1-methyl-4-oxoquinoline-3-carboxylate

methyl 2-[(1s)-1,2-dimethoxy-2-oxoethyl]-1-methyl-4-oxoquinoline-3-carboxylate

C16H17NO6 (319.1055822)


   

(2e)-n-(4-{[(2z)-3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

(2e)-n-(4-{[(2z)-3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)-3-phenylprop-2-enimidic acid

C17H21NO3S (319.12420760000003)


   

16-methoxy-13,13-dimethyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,11,14,16,18-octaene

16-methoxy-13,13-dimethyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,11,14,16,18-octaene

C20H17NO3 (319.1208372)


   

n-[(2s)-1-(3,4-dihydroxyphenyl)-3-hydroxypropan-2-yl]-3,4-dihydroxybenzenecarboximidic acid

n-[(2s)-1-(3,4-dihydroxyphenyl)-3-hydroxypropan-2-yl]-3,4-dihydroxybenzenecarboximidic acid

C16H17NO6 (319.1055822)


   

5,6-dihydroxy-3-(hydroxymethyl)-6-(1h-indol-3-ylmethyl)-1-methoxy-3h-pyrazin-2-one

5,6-dihydroxy-3-(hydroxymethyl)-6-(1h-indol-3-ylmethyl)-1-methoxy-3h-pyrazin-2-one

C15H17N3O5 (319.1168152)


   

10-hydroxy-10-[5-(hydroxymethyl)-1-methyl-2,4-dioxopyrrolidin-3-ylidene]deca-2,4,6,8-tetraenoic acid

10-hydroxy-10-[5-(hydroxymethyl)-1-methyl-2,4-dioxopyrrolidin-3-ylidene]deca-2,4,6,8-tetraenoic acid

C16H17NO6 (319.1055822)


   

methyl 2-[(1r)-1,2-dimethoxy-2-oxoethyl]-1-methyl-4-oxoquinoline-3-carboxylate

methyl 2-[(1r)-1,2-dimethoxy-2-oxoethyl]-1-methyl-4-oxoquinoline-3-carboxylate

C16H17NO6 (319.1055822)


   

(2e,4e,6e,8e)-10-hydroxy-10-[(3e,5s)-5-(hydroxymethyl)-1-methyl-2,4-dioxopyrrolidin-3-ylidene]deca-2,4,6,8-tetraenoic acid

(2e,4e,6e,8e)-10-hydroxy-10-[(3e,5s)-5-(hydroxymethyl)-1-methyl-2,4-dioxopyrrolidin-3-ylidene]deca-2,4,6,8-tetraenoic acid

C16H17NO6 (319.1055822)